ES2193399T3 - Derivados del acido nodulisporico. - Google Patents

Derivados del acido nodulisporico.

Info

Publication number
ES2193399T3
ES2193399T3 ES97941580T ES97941580T ES2193399T3 ES 2193399 T3 ES2193399 T3 ES 2193399T3 ES 97941580 T ES97941580 T ES 97941580T ES 97941580 T ES97941580 T ES 97941580T ES 2193399 T3 ES2193399 T3 ES 2193399T3
Authority
ES
Spain
Prior art keywords
derivatives
nodulisporic acid
nodulisporic
acid
antiparasitaries
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97941580T
Other languages
English (en)
Inventor
Peter T Meinke
Thomas Shih
Michael H Fisher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of ES2193399T3 publication Critical patent/ES2193399T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N49/00—Biocides, pest repellants or attractants, or plant growth regulators, containing compounds containing the group, wherein m+n>=1, both X together may also mean —Y— or a direct carbon-to-carbon bond, and the carbon atoms marked with an asterisk are not part of any ring system other than that which may be formed by the atoms X, the carbon atoms in square brackets being part of any acyclic or cyclic structure, or the group, wherein A means a carbon atom or Y, n>=0, and not more than one of these carbon atoms being a member of the same ring system, e.g. juvenile insect hormones or mimics thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Insects & Arthropods (AREA)
  • Agronomy & Crop Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Air Bags (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Fodder In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Reduction Or Emphasis Of Bandwidth Of Signals (AREA)
  • Cookers (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVOS DERIVADOS DEL ACIDO NODULISPORICO, QUE SON AGENTES ACARICIDAS, ANTIPARASITARIOS, INSECTICIDAS Y ANTIHELMINTICOS.
ES97941580T 1996-09-19 1997-09-15 Derivados del acido nodulisporico. Expired - Lifetime ES2193399T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71601296A 1996-09-19 1996-09-19

Publications (1)

Publication Number Publication Date
ES2193399T3 true ES2193399T3 (es) 2003-11-01

Family

ID=24876362

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97941580T Expired - Lifetime ES2193399T3 (es) 1996-09-19 1997-09-15 Derivados del acido nodulisporico.

Country Status (12)

Country Link
EP (1) EP0931082B1 (es)
JP (1) JP3502103B2 (es)
AT (1) ATE234841T1 (es)
AU (1) AU712773B2 (es)
CA (1) CA2265881C (es)
DE (1) DE69720016T2 (es)
DK (1) DK0931082T3 (es)
ES (1) ES2193399T3 (es)
NZ (1) NZ334308A (es)
PT (1) PT931082E (es)
WO (1) WO1998012196A1 (es)
ZA (1) ZA978406B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7375093B2 (en) 2002-07-05 2008-05-20 Intrexon Corporation Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
US20040077703A1 (en) * 2002-10-02 2004-04-22 Soll Mark D. Nodulisporic acid derivative spot-on formulations for combating parasites
US20050234119A1 (en) * 2004-04-16 2005-10-20 Soll Mark D Antiparasitical agents and methods for treating, preventing and controlling external parasites in animals
MX358352B (es) 2013-03-28 2018-08-15 Dow Global Technologies Llc Combinación sinergística de un compuesto de clorotolurón y oit para la protección de una película seca.
KR20230061465A (ko) 2020-09-04 2023-05-08 엘랑코 유에스 인코포레이티드 기호성 제형

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399582A (en) * 1993-11-01 1995-03-21 Merck & Co., Inc. Antiparasitic agents
SK284840B6 (sk) 1995-03-20 2005-12-01 Merck & Co., Inc. Deriváty kyseliny nodulisporovej a farmaceutický prostriedok s ich obsahom
US5595991A (en) * 1995-03-20 1997-01-21 Merck & Co., Inc. Anthelmintic use of nodulisporic acid and analogs thereof
ZA962203B (en) * 1995-03-20 1996-09-04 Merck & Co Inc Nodulisporic acid derivatives

Also Published As

Publication number Publication date
EP0931082A4 (en) 1999-11-17
EP0931082A1 (en) 1999-07-28
EP0931082B1 (en) 2003-03-19
AU4346297A (en) 1998-04-14
JP3502103B2 (ja) 2004-03-02
AU712773B2 (en) 1999-11-18
DE69720016D1 (de) 2003-04-24
CA2265881C (en) 2004-05-18
JP2001501195A (ja) 2001-01-30
ATE234841T1 (de) 2003-04-15
NZ334308A (en) 2000-08-25
CA2265881A1 (en) 1998-03-26
PT931082E (pt) 2003-06-30
ZA978406B (en) 1998-03-19
DE69720016T2 (de) 2004-01-22
WO1998012196A1 (en) 1998-03-26
DK0931082T3 (da) 2003-04-22

Similar Documents

Publication Publication Date Title
HN1999000131A (es) Derivados del acido hidroxi pipecolato hidroxamico.
NO974321D0 (no) Nodulisporsyrederivater
BG104247A (bg) Производни на резорцинола
ES2098140T3 (es) Liosferas que contienen gonadotropina.
HN1997000126A (es) Derivados de indazol
HN1998000086A (es) Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
ES2105913T3 (es) Composiciones para el teñido de las fibras queratinicas que comprenden un orto-diamino pirazol y una sal de manganeso, procedimiento de teñido que utiliza estas composiciones.
UY24553A1 (es) Compuestos insecticidas de tipo 5- amino -4-etilsulfinil-pirazol
HN1999000066A (es) Formulaciones farmaceuticas
CO4930259A1 (es) Derivados 6,6-heterobiciclicos sustituidos y composiciones farmaceuticas que los contienen
ES2183473T3 (es) Derivados de acido piridonacarboxilico como agentes antibacterianos.
HN1997000079A (es) Analogos de indazol sustituido.
NO965516L (no) Sterolderivater anvendt til regulering av meiose
ES2192668T3 (es) Compuestos biciclicos-aromaticos.
ES2119203T3 (es) Derivados de poliamina n-alquiltio utilizados como agentes radioprotectores.
ES2156642T3 (es) Composicion que comprende un derivado de acido cinamico y un polimero poliaminado.
ES2139669T3 (es) Nuevos derivados triciclicos de indan-2-mercaptoacetilamida 2-substituidos utiles como inhibidores de la encefalinasa.
BG100248A (bg) Инхибитори на скваленсинтетаза
ES2142490T3 (es) Ciclopeptolidos.
HN1997000153A (es) Pirazoles plaguicidas y derivados
MX9700854A (es) Derivados de azabicicloheptano n-substituidos utiles como neurolepticos.
HN1998000102A (es) Composiciones solubilizadas de sertralina
EA200100853A1 (ru) Резорциновая композиция
ES2154692T3 (es) Dihidrofarnesal.
ES2171653T3 (es) Composiciones que poseen propiedades antivirales y procedimiento de obtencion.